$LIVN
LivaNova PLC Stock $livn

$livn Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000163969123000076 Filed on July 26, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$286.1M	$293.9M
YoY Change	13.26%	15.63%
Cost Of Revenue	$84.31M	$88.69M
YoY Change	3.21%	27.05%
Gross Profit	$201.8M	$205.2M
YoY Change	18.07%	11.31%
Gross Profit Margin	70.53%	69.82%
Selling, General & Admin	$134.8M	$125.9M
YoY Change	17.59%	8.06%
% of Gross Profit	66.79%	61.34%
Research & Development	$46.54M	$51.12M
YoY Change	30.28%	49.36%
% of Gross Profit	23.06%	24.91%
Depreciation & Amortization	$13.00M	$12.48M
YoY Change	12.55%	4.65%
% of Gross Profit	6.44%	6.08%
Operating Expenses	$181.3M	$187.8M
YoY Change	20.6%	24.62%
Operating Profit	$4.458M	$17.38M
YoY Change	-103.38%	-45.28%
Interest Expense	$14.99M	$509.0K
YoY Change	18.36%	-96.46%
% of Operating Profit	336.16%	2.93%
Other Income/Expense, Net	$172.0K	-$12.61M
YoY Change	-137.47%	5477.43%
Pretax Income	-$1.978M	$5.280M
YoY Change	-98.14%	-72.21%
Income Tax	$5.308M	$4.097M
% Of Pretax Income		77.59%
Net Earnings	-$7.318M	$1.155M
YoY Change	-93.18%	-92.98%
Net Earnings / Revenue	-2.56%	0.39%
Basic Earnings Per Share	-$0.14	$0.02
Diluted Earnings Per Share	-$0.14	$0.02
COMMON SHARES
Basic Shares Outstanding	53.88M shares	53.77M shares
Diluted Shares Outstanding	53.99M shares	53.98M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$233.9M	$222.9M
YoY Change	1.21%	104.49%
Cash & Equivalents	$233.9M	$222.9M
Short-Term Investments
Other Short-Term Assets	$368.5M	$376.6M
YoY Change	13.05%	2.74%
Inventory	$161.5M	$156.4M
Prepaid Expenses
Receivables	$189.9M	$185.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$953.9M	$941.8M
YoY Change	12.06%	22.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$149.3M	$183.7M
YoY Change	7.29%	28.21%
Goodwill	$767.1M	$779.2M
YoY Change	3.33%	-13.23%
Intangibles	$347.7M	$357.4M
YoY Change	-4.75%	-8.21%
Long-Term Investments	$22.70M	$21.73M
YoY Change	62.83%	55.57%
Other Assets	$12.12M	$57.63M
YoY Change	-26.77%	236.14%
Total Long-Term Assets	$1.376B	$1.400B
YoY Change	1.02%	-10.52%
TOTAL ASSETS
Total Short-Term Assets	$953.9M	$941.8M
Total Long-Term Assets	$1.376B	$1.400B
Total Assets	$2.329B	$2.342B
YoY Change	5.27%	0.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.78M	$78.21M
YoY Change	-9.82%	5.2%
Accrued Expenses	$89.68M	$127.1M
YoY Change	13.51%	51.34%
Deferred Revenue	$10.97M	$11.04M
YoY Change	9.11%	21.38%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$18.42M	$19.07M
YoY Change	-1.78%	495.13%
Total Short-Term Liabilities	$295.4M	$288.2M
YoY Change	2.56%	9.2%
LONG-TERM LIABILITIES
Long-Term Debt	$568.2M	$568.0M
YoY Change	9.63%	23.52%
Other Long-Term Liabilities	$46.26M	$235.9M
YoY Change	9.14%	399.89%
Total Long-Term Liabilities	$614.4M	$803.9M
YoY Change	9.59%	58.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$295.4M	$288.2M
Total Long-Term Liabilities	$614.4M	$803.9M
Total Liabilities	$1.104B	$1.101B
YoY Change	3.57%	4.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$982.8M	-$975.5M
YoY Change	-0.29%	11.06%
Common Stock	$2.263B	$2.252B
YoY Change	1.66%	1.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$56.00K	$95.00K
YoY Change	-85.26%	-76.07%
Treasury Stock Shares
Shareholders Equity	$1.225B	$1.241B
YoY Change
Total Liabilities & Shareholders Equity	$2.329B	$2.342B
YoY Change	5.27%	0.23%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$7.318M	$1.155M
YoY Change	-93.18%	-92.98%
Depreciation, Depletion And Amortization	$13.00M	$12.48M
YoY Change	12.55%	4.65%
Cash From Operating Activities	$18.20M	-$17.94M
YoY Change	-48.93%	75.11%
INVESTING ACTIVITIES
Capital Expenditures	$8.800M	$5.659M
YoY Change	-245.67%	-192.36%
Acquisitions
YoY Change
Other Investing Activities	-$1.300M	-$996.0K
YoY Change	-719.05%	-90.06%
Cash From Investing Activities	-$10.10M	-$6.655M
YoY Change	73.21%	-58.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.300M	36.01M
YoY Change	-105.87%	-669.84%
NET CHANGE
Cash From Operating Activities	18.20M	-17.94M
Cash From Investing Activities	-10.10M	-6.655M
Cash From Financing Activities	-4.300M	36.01M
Net Change In Cash	3.800M	11.42M
YoY Change	-96.31%	-134.92%
FREE CASH FLOW
Cash From Operating Activities	$18.20M	-$17.94M
Capital Expenditures	$8.800M	$5.659M
Free Cash Flow	$9.400M	-$23.60M
YoY Change	-77.45%	473.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Interest Expense InterestExpense	14809000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	14388000	usd
	us-gaap	Interest Expense InterestExpense	28246000	usd
	us-gaap	Interest Expense InterestExpense	22228000	usd
CY2023Q2	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	2713000	usd
CY2022Q2	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	1633000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	28260000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	5537000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5280000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19001000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15048000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24570000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4097000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2515000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6468000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5052000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-42000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-55000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-81000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1155000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1155000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	16444000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53803000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53977000	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1155000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5453000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6608000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	222935000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11862000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183110000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	129379000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	31708000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26321000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	886136000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147187000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	768787000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	368559000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35830000	usd
CY2022Q4	us-gaap	Investments Investments	16266000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1384000	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	54393000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16231000	usd
CY2022Q4	us-gaap	Assets Assets	2294773000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	23434000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	74310000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81481000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	29481000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	16505000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	72187000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	297398000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518067000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	85292000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8516000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29548000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	16804000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	85675000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	45849000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1087149000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53903564	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53830387	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	82424000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2157724000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-48119000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-984030000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	287315	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	375000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1207624000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2294773000	usd
	us-gaap	Net Income Loss NetIncomeLoss	19437000	usd
	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	25332000	usd
	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	5098000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	12747000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	12917000	usd
	us-gaap	Depreciation Depreciation	11096000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11721000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7334000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-27359000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-198000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1987000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	707000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	875000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25439000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16461000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8321000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2846000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4638000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-19387000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2738000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	116000	usd
	livn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	-7257000	usd
	livn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	-2064000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2820000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15580000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13344000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11342000	usd
	livn	Purchases Of Investments PurchasesOfInvestments	5409000	usd
	livn	Purchases Of Investments PurchasesOfInvestments	781000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8857000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-614000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	650000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18139000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21630000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	50000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	218342000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	11808000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	784000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5841000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8223000	usd
	us-gaap	Repayments Of Short Term Debt Maturing In More Than Three Months RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	1974000	usd
	us-gaap	Repayments Of Short Term Debt Maturing In More Than Three Months RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	0	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	589000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	1788000	usd
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	2861000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-187000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	295000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30779000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	208557000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3282000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3730000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18742000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	198777000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515618000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	207992000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	534360000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	406769000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsThe Company has reclassified certain prior period amounts on the condensed consolidated balance sheets for comparative purposes. These reclassifications did not have a material effect on LivaNova’s financial condition.
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	15586000	usd
	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	16791000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	32377000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	586395000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	538959000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	18444000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20892000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	567951000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518067000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	311400000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301400000	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	42253000	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	53818000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	55726000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	91561000	usd
CY2023Q2	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	10800000	usd
	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	12200000	usd
CY2023Q2	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	22352000	usd
CY2023Q2	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	3065000	usd
CY2016Q2	livn	Reimbursed Legal Fees ReimbursedLegalFees	292000	eur
	livn	Reimbursed Legal Fees ReimbursedLegalFees	318732000	usd
CY2021Q1	livn	Utilities Operating Expense Environmental Maintenance UtilitiesOperatingExpenseEnvironmentalMaintenance	1000000	eur
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1227341000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6659000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1155000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5453000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1240608000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1291854000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12443000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	16444000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-38738000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1282003000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1207624000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11919000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8525000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12540000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1240608000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1294645000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15614000	usd
	us-gaap	Net Income Loss NetIncomeLoss	19437000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-47693000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1282003000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	13073000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	13073000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	533000	usd
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	533000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12540000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-47524000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-47524000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	169000	usd
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	169000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-47693000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	2400000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	2500000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.776
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.430
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.132
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	500000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53803000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53506000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53713000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53420000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	174000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	574000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	229000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	724000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53977000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54080000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53942000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54144000	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q2	livn	Number Of Geographic Regions In Which Entity Operates NumberOfGeographicRegionsInWhichEntityOperates	3	geographic_region
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	557300000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	494326000	usd
CY2022Q2	livn	Other Operating Income Expense OtherOperatingIncomeExpense	-26733000	usd
	livn	Other Operating Income Expense OtherOperatingIncomeExpense	-57886000	usd
	livn	Other Operating Income Expense OtherOperatingIncomeExpense	-56163000	usd
	us-gaap	Interest Expense InterestExpense	28246000	usd
	us-gaap	Interest Expense InterestExpense	22228000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	28260000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	5537000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15048000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24570000	usd
CY2023Q2	us-gaap	Assets Assets	2341555000	usd
CY2022Q4	us-gaap	Assets Assets	2294773000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	768787000	usd
	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	10425000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	779212000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149568000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147187000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	86929000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	70027000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	18521000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15508000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	50996000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	43844000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	156446000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	129379000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	11200000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8200000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	12071000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8653000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11042000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10226000	usd
CY2023Q2	livn	Interest Payable Current Net InterestPayableCurrentNet	7493000	usd
CY2022Q4	livn	Interest Payable Current Net InterestPayableCurrentNet	0	usd
CY2023Q2	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	7401000	usd
CY2022Q4	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	6414000	usd
CY2023Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4362000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3950000	usd
CY2023Q2	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	4432000	usd
CY2022Q4	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	1678000	usd
CY2023Q2	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	904000	usd
CY2022Q4	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	2045000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18326000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26230000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	82038000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81481000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15600000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14100000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1008000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3132000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	10064000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	77000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-407000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-261000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	28260000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	5537000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	222935000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214172000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214172000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	311425000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	534360000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515618000	usd
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001639691-23-000076-index-headers.html	Edgar Link	pending
R3.htm	Edgar Link	pending
0001639691-23-000076-index.html	Edgar Link	pending
0001639691-23-000076.txt	Edgar Link	pending
0001639691-23-000076-xbrl.zip	Edgar Link	pending
executioncopyreleaseagre.htm	Edgar Link	pending
executioncopyreleaseagre001.jpg	Edgar Link	pending
executioncopyreleaseagre002.jpg	Edgar Link	pending
executioncopyreleaseagre003.jpg	Edgar Link	pending
executioncopyreleaseagre004.jpg	Edgar Link	pending
executioncopyreleaseagre005.jpg	Edgar Link	pending
executioncopyreleaseagre006.jpg	Edgar Link	pending
executioncopyreleaseagre007.jpg	Edgar Link	pending
executioncopyreleaseagre008.jpg	Edgar Link	pending
executioncopyreleaseagre009.jpg	Edgar Link	pending
executioncopyreleaseagre010.jpg	Edgar Link	pending
executioncopyreleaseagre011.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
livn-20230630.htm	Edgar Link	pending
livn-20230630.xsd	Edgar Link	pending
livn-20230630_g1.jpg	Edgar Link	pending
livn-2023630xex311.htm	Edgar Link	pending
livn-2023630xex312.htm	Edgar Link	pending
livn-2023630xex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
livn-20230630_cal.xml	Edgar Link	unprocessable
livn-20230630_def.xml	Edgar Link	unprocessable
livn-20230630_lab.xml	Edgar Link	unprocessable
livn-20230630_pre.xml	Edgar Link	unprocessable
livn-20230630_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
williamkozy_04202023.htm	Edgar Link	pending
williamkozy_04202023001.jpg	Edgar Link	pending
williamkozy_04202023002.jpg	Edgar Link	pending
williamkozy_04202023003.jpg	Edgar Link	pending
williamkozy_04202023004.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIVN
LivaNova PLC Stock $livn

2023 Q3 Form 10-Q Financial Statement

#000163969123000076 Filed on July 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN LivaNova PLC Stock $livn

2023 Q3 Form 10-Q Financial Statement

#000163969123000076 Filed on July 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN
LivaNova PLC Stock $livn